Abstract
Purpose
To compare the characteristics and outcomes of rectal cancer patients with local recurrence at a perianastomotic site (PA), a surgical field (SF) site, or in lateral lymph nodes (LLN).
Methods
A total of 114 consecutive patients who underwent surgery for recurrent, non-metastatic rectal cancer at a single comprehensive cancer center between 1997 and 2012 were grouped on the basis of radiographic assessment of type of recurrence: PA, 76 (67%) patients; SF, 25 (22%) patients; LLN, 13 (11%) patients. Demographic, clinical, and pathological features were compared between the three groups, as were disease-free survival (DFS) and overall survival (OS).
Results
Recurrence type was associated with positive circumferential margin in the primary resection (PA, 4 [6%]; SF, 4 [19%]; LLN, 3 [25%]; P = 0.027), prior neoadjuvant therapy for the primary tumor (PA, 57 [75%]; SF, 18 [72%]; LLN, 4 [31%]; P = 0.007), and location of the primary tumor in the upper rectum (PA, 33 [45%]; SF, 5 [23%]; LLN, 1 [8%]; P < 0.001). Patients with PA had longer median DFS (PA, 5.1 years; SF, 1.5 years; LLN, 1.2 years; P = 0.036). There was a non-significant trend toward longer OS and higher rates of R0 resection for PA.
Conclusion
Type of recurrence after salvage surgery for locally recurrent rectal cancer is associated with longer DFS in patients with PA recurrence.
Similar content being viewed by others
References
Heriot AG, Tekkis PP, Darzi A, Mackay J (2006) Surgery for local recurrence of rectal cancer. Colorectal Dis 8:733–747
Hagemans JAW, van Rees JM, Alberda WJ, Rothbarth J, Nuyttens J, van Meerten E et al (2020) Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre. Eur J Surg Oncol 46:448–454
MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet (London, England) 341:457–460
Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A et al (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results–EORTC 22921. J Clin Oncol 23:5620–5627
Cedermark B, Dahlberg M, Glimelius B, Pahlman L, Rutqvist LE, Wilking N (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987
Syk E, Torkzad MR, Blomqvist L, Ljungqvist O, Glimelius B (2006) Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg 93:113–119
Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE (1984) Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53:1354–1362
Enriquez-Navascues JM, Borda N, Lizerazu A, Placer C, Elosegui JL, Ciria JP et al (2011) Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol 17:1674–1684
Bernstein TE, Endreseth BH, Romundstad P, Wibe A (2009) Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 96:1348–1357
Kusters M, Wallner C, Lange MM, DeRuiter MC, van de Velde CJ, Moriya Y et al (2010) Origin of presacral local recurrence after rectal cancer treatment. Br J Surg 97:1582–1587
Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O, Norwegian Rectal Cancer Group (2004) Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 47: 48–58.
Suzuki K, Dozois RR, Devine RM, Nelson H, Weaver AL, Gunderson LL et al (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39:730–736
Wanebo HJ, Antoniuk P, Koness RJ, Levy A, Vezeridis M, Cohen SI et al (1999) Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 42:1438–1448
Yamada K, Ishizawa T, Niwa K, Chuman Y, Akiba S, Aikou T (2001) Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 88:988–993
Belli F, Sorrentino L, Gallino G, Gronchi A, Scaramuzza D, Valvo F et al (2020) A proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision-making. J Surg Oncol 122:350–359
Sorrentino L, Belli F, Valvo F, Villa S, Guaglio M, Scaramuzza D et al (2020) Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: impact of anatomical site of pelvic recurrence on long-term results. Surg Oncol 35:89–96
Alberda WJ, Verhoef C, Schipper ME, Nuyttens JJ, Rothbarth J, de Wilt JH et al (2015) The importance of a minimal tumor-free resection margin in locally recurrent rectal cancer. Dis Colon Rectum 58:677–685
Rahbari NN, Ulrich AB, Bruckner T, Munter M, Nickles A, Contin P et al (2011) Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg 253:522–533
Williamson JS, Quyn AJ, Sagar PM (2020) Rectal cancer lateral pelvic sidewall lymph nodes: a review of controversies and management. Br J Surg 107:1562–1569
Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M et al (2004) Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 47:1599–1606
Wiig JN, Giercksky KE, Tveit KM (2014) Intraoperative radiotherapy for locally advanced or locally recurrent rectal cancer: does it work at all? Acta Oncol 53:865–876
Bosman SJ, Holman FA, Nieuwenhuijzen GA, Martijn H, Creemers GJ, Rutten HJ (2014) Feasibility of reirradiation in the treatment of locally recurrent rectal cancer. Br J Surg 101:1280–1289
Holman FA, Bosman SJ, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA (2017) Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: results of 565 patients of two major treatment centres. Eur J Surg Oncol 43:107–117
Brady JT, Xu Z, Scarberry KB, Saad A, Fleming FJ, Remzi FH et al (2018) Evaluating the current status of rectal cancer care in the US: where we stand at the Start of the Commission on Cancer’s National Accreditation Program for Rectal Cancer. J Am Coll Surg 226:881–890
Stringfield SB, Fleshman JW (2021) Specialization improves outcomes in rectal cancer surgery. Surg Oncol 37: 101568.
Acknowledgements
We gratefully acknowledge Minghe Wang, Bryan D. Loh, Kun Cao, Gerd R. Silberhumer, and Sanjun Cai for their contributions to this study.
Funding
This study was funded in part by the NIH/NCI Memorial Sloan Kettering Cancer Center Support Grant P30 CA008748. Jonathan B. Yuval’s research fellowship at Memorial Sloan Kettering was funded in part by grant T32 CA009501 from the National Cancer Institute.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethics approval
This study was approved by an institutional review board.
Conflict of interest
Dr. Romesser has research funding from and is a consultant for EMD Serono and has received travel support from Elekta. Dr. Garcia-Aguilar has received support from Medtronic, Johnson and Johnson, and Intuitive Surgical. Dr. Smith has served as a clinical advisor for Guardant Health, Inc.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Previous presentation
2018 Annual Scientific Meeting of the American Society of Colon and Rectal Surgeons, May 19–23, 2018, Nashville, Tennessee.
Rights and permissions
About this article
Cite this article
Jimenez-Rodriguez, R.M., Yuval, J.B., Sauve, CE.G. et al. Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer. Int J Colorectal Dis 36, 2603–2611 (2021). https://doi.org/10.1007/s00384-021-03998-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-021-03998-4